<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>PekingHSC: Judging Session</title>
        <link>https://video.igem.org/videos/watch/8b706949-feee-4b2c-9b4e-edf8e9edb36f</link>
        <description>Chromosome microdeletion syndromes reduce the expression of multiple genes, yet replacing deleted genes remains challenging. HEPHA-RNA offers an alternative by enhancing translation from the remaining allele without adding DNA. Its Binding Domain recognizes the target mRNA’s 3′ UTR, while its Effector Domain recruits the 60S ribosomal subunit. For Wolf–Hirschhorn syndrome, LETM1- and NSD2-targeting domains enhanced luciferase reporter expression. LETM1-targeting domains increased endogenous protein levels to over 1.5-fold those of a non-binding control across two Western blot experiments, without significantly increasing mRNA abundance. NSD2 upregulation also increased H3K36me2, a histone mark associated with gene regulation. Our measurement workflow combines off-target screening, luciferase assays, protein and mRNA quantification, and dose optimization. Computational models connect phenotype-guided gene prioritization and binding-site analysis with AAV delivery considerations. Through Integrated Human Practices and PHAROS, engagement with clinicians, researchers, and patients informed a patient-centered approach spanning diagnosis, treatment, care, and social inclusion.</description>
        <lastBuildDate>Fri, 20 Nov 2026 21:53:10 GMT</lastBuildDate>
        <docs>https://validator.w3.org/feed/docs/rss2.html</docs>
        <generator>PeerTube - https://video.igem.org</generator>
        <image>
            <title>PekingHSC: Judging Session</title>
            <url>https://video.igem.org/client/assets/images/icons/icon-1500x1500.png</url>
            <link>https://video.igem.org/videos/watch/8b706949-feee-4b2c-9b4e-edf8e9edb36f</link>
        </image>
        <copyright>All rights reserved, unless otherwise specified in the terms specified at https://video.igem.org/about and potential licenses granted by each content's rightholder.</copyright>
        <atom:link href="https://video.igem.org/feeds/video-comments.xml?videoId=8b706949-feee-4b2c-9b4e-edf8e9edb36f" rel="self" type="application/rss+xml"/>
    </channel>
</rss>